Our Mission to Make Recovery Accessible to All

The data behind the numbers we quote across this site. Every figure comes from anonymized data from people using Bia.

86%

record a lower severity score within two weeks

67%

average drop in severity from chapter 1 to chapter 11

41%

lower peak discomfort by a person's twelfth exposure

80,000+

exposures completed in Bia

Phobia severity across the program

Severity 0 – 5 Average across Bia users
5 4 3 2 1 0 3.8 at chapter 1 1.3 at chapter 11 Chapter 1 Chapter 11

Average severity falls from 3.8 to 1.3 on the 0 to 5 scale used in the app. On the 0 to 40 SMSP-A total that is 30.4 down to 10.0, a drop of 67 percent.

Peak discomfort during exposures

Average of the highest 0 to 10 discomfort rating a person gives during an exposure. 5.11 on a first exposure, 3.01 on a twelfth.

The measures

Severity Measure for Specific Phobia

Ten questions published by the American Psychiatric Association. Scored 0 to 40, shown in the app on a 0 to 5 scale. Taken at the start, then every two weeks and at each milestone.

Obsessive Compulsive Inventory, Revised

Used in place of the phobia measure for contamination OCD.

Subjective units of distress

A 0 to 10 discomfort rating collected at each step of every exposure. 80,000+ exposures have been rated this way.

Adults and children

Adults

Most of the improvement is recorded in the first six weeks. Gains continue more slowly after that. Breaks of 30 days or more are common.

Children

Improvement is recorded faster, often within the first two weeks. Children complete more exercises in less time and take fewer breaks.

Where these numbers come from

  • 1,186 people have recorded two or more severity ratings, taken about two weeks apart. 86 percent scored lower the second time.
  • Severity figures are per-chapter averages across Bia users at that point in the program.
  • Peak discomfort is the highest 0 to 10 rating given while completing an exposure.
  • Results are aggregated and anonymized from people using Bia on their own. This is not a randomized controlled trial, and individual results vary.
  • Bia is not a replacement for therapy.
  • Reporting on this page cannot be traced back to an individual. Bia never sells your data.

Research, talks, and partners

The evidence and the people behind Bia.

Mini-skills presentation - NASP 2026
Bia at the NASP 2026 conference

Filling the Gaps: Emetophobia Assessment and Treatment in Schools

Lagunas, N., Thompson, A., Schuler, C., Arenare, L., & Schaller, W.

National Association of School Psychologists, 2026

Symposium - ADAA 2026
Bia at the ADAA 2026 conference

Innovations in Digital Care for Emetophobia: Findings from Bia, a Self-Guided Program

Kaur, K., Asnaani, A., Lagunas, N., Franklin, B. E., Yusko, D., & Schaller, W.

Anxiety and Depression Association of America, 2026

Research Partner

University of Utah

Research Partner, Manuscript under Review

Paper presentation - WCCBT 2026
Bia at the WCCBT 2026 congress

Overcoming emetophobia with a journey through Bia: Examining the effectiveness and uptake of an online self-guided, evidence-based treatment program

Lagunas, N., Schaller, W., Kaur, K., Franklin, B. E., Yusko, D., & Asnaani, A.

World Confederation of Cognitive and Behavioral Therapies Congress, 2026

Clinical Partner

Center for Anxiety and Behavior Therapy

Clinical Partnership, The Emetophobia Institute

Interested in partnering on research?

We collaborate with clinicians and researchers advancing exposure therapy. Bia's powerful client app and clinician portal provides significant data and opportunities to improve exposure. Please reach out anytime.

willy@biajourney.com

Research

Our first manuscript reviews two years of anonymized self-guided results and was written with the University of Utah. It is pending peer review. We presented at NASP, ADAA, and WCCBT in 2026.

Ready to start?

Choose your path to recovery

Bia app icon
Self-Guided with Bia Start at your own pace, cancel anytime
Get Started